MediWound raises $20 million from Israeli institutions

Clal Biotech: There is little chance that Gamida Cell will carry out a new clinical trial; the holding is no longer material.

By GALI WEINREB, GLOBES
August 20, 2013 22:30
Dollar bills.

Dollar bills 150. (photo credit: Steve Marcus / Reuters)

.


Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS

Cookie Settings